In contrast, none of the 18 cases of metastatic pancreatic ductal adenocarcinomas were positive for PSMA (0/8, 0.0%) (p < 0.01) (Table 1). This evidence concerns the gene FOLH1 and pancreatic ductal adenocarcinoma.